Page last updated: 2024-08-24

etofibrate and Metabolic Syndrome

etofibrate has been researched along with Metabolic Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fenselau, S; Schrezenmeir, J; Steinmetz, A	1

Reviews

1 review(s) available for etofibrate and Metabolic Syndrome

Article	Year
Treatment of dyslipoproteinemia in the metabolic syndrome. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2001, Volume: 109, Issue:4 Topics: Arteriosclerosis; Clofibric Acid; Coronary Disease; Diabetes Mellitus, Type 2; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Metabolic Syndrome	2001

Article

Year

Treatment of dyslipoproteinemia in the metabolic syndrome.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2001, Volume: 109, Issue:4

Topics: Arteriosclerosis; Clofibric Acid; Coronary Disease; Diabetes Mellitus, Type 2; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Metabolic Syndrome

2001